Risk of Cancer Among Pantoprazole Users
Status
Completed
Conditions
Esophagitis
Treatments
Other: Does not apply
Details and patient eligibility
About
The primary objective is to assess whether the risk of gastric cancer is increased in pantoprazole users compared to users of other proton pump inhibitors.
Full description
All subjects who met the inclusion criteria were included in the study.
Enrollment
61,864 patients
Sex
All
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Patients who have used pantoprazole or other proton pump inhibitors, enrollment in the health maintenance organization for at least 6 months, age 18 years or older.
Exclusion criteria
- Use of any proton pump inhibitor before study entry, any cancer diagnosis recorded in the medical history, diagnosis of Zollinger-Ellison Syndrome in medical history.
Trial design
61,864 participants in 2 patient groups
Pantoprazole
Description:
Patients who received treatment with pantoprazole tablets for at least 240 days within a 12-month period from 2000 through 2003.
Treatment:
Other: Does not apply
Other: Does not apply
Other proton pump inhibitors
Description:
Patients who received treatment with any other proton pump inhibitor for at least 240 days within a 12-month period from 1996 through 2003.
Treatment:
Other: Does not apply
Other: Does not apply
Trial contacts and locations
0
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems